[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353996-105":59,"doc-detail-353996-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stiripentol-directly-attenuates-immunosuppression-of-tumor-infiltrating-myeloid-cells-to-potentiate-anti-pd-1-efficacy","Stiripentol directly attenuates immunosuppression of tumor-infiltrating myeloid cells to potentiate anti-PD-1 efficacy","","Immune checkpoint blockade (ICB) shows strong benefits across cancers, yet resistance persists due to an immunosuppressive tumor microenvironment (TME). Stiripentol (STP), a clinically used antiepileptic drug, has been repurposed as a lactate dehydrogenase A inhibitor that may disrupt tumor metabolism. This study evaluates how STP remodels immunosuppression in tumors and whether it synergizes with anti-PD-1 therapy through effects on myeloid cells, lactate levels, and T-cell activity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stiripentol-directly-attenuates-immunosuppression-of-tumor-infiltrating-myeloid-cells-to-potentiate-anti-pd-1-efficacy/353996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stiripentol-directly-attenuates-immunosuppression-of-tumor-infiltrating-myeloid-cells-to-potentiate-anti-pd-1-efficacy/353996.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study investigate about stiripentol (STP) and anti-PD-1?","Question",{"text":112,"@type":113},"It tests whether STP directly remodels the immunosuppressive tumor microenvironment and enhances the efficacy of anti-PD-1 therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the combination of STP and anti-PD-1 affect the tumor and immune cells?",{"text":117,"@type":113},"The combination suppresses 4T1 tumor growth, reduces immunosuppressive MDSCs and M2-like TAMs, and reactivates CD8+ T cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-suppressive pathways of myeloid cells does STP target?",{"text":121,"@type":113},"STP directly reprograms MDSCs by inducing MHC II+ differentiation and downregulating immunosuppressive genes, and it promotes M2-to-M1 macrophage repolarization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353996,1790229739,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Xie etal. BMC Cancer (2026) 26:439 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15793-x](https://doi.org/10.1186/s12885-026-15793-x)  \nRESEARCH Open Access  \nStiripentol directly attenuates   \nimmunosuppression of tumor-infiltrating myeloid cells to potentiate anti-PD-1 efficacy  \nZhiqi Xie1,2*†, Kexin Wang3†, Jiayi Liu2†, Ziyi Hong4, Yuanzhen Jin2, Linying Wang3, Masashi Tachibana5, Jian Liu6,7, Meihua Lin6,7, Zeren Shen4* and Jinjin Shao3*  \nAbstract  \nBackground Immune checkpoint blockade (ICB) therapy demonstrates significant efficacy across multiple malignancies, yet resistance remains prevalent. Recent studies have repositioned the clinically approved antiepileptic drug stiripentol (STP) as a potent lactate dehydrogenase A inhibitor that effectively disrupts tumor metabolic reprogramming, thereby reinstating tumor control. Despite its promising antineoplastic activity, the direct impact of STP on immune cells and its potential synergy with anti-PD-1 antibodies remain unexplored.  \nMethods We used an orthotopic 4T1 breast cancer model to evaluate whether STP remodels the immunosuppressive tumor microenvironment and enhances anti-PD-1 efficacy. Tumor growth was monitored, and immune cell profiles in tumors and blood were analyzed by flow cytometry. Lactate levels and chemokine expression in tumor tissue were also assessed. In vitro, the effects of STP on 4T1 cell proliferation and lactate secretion, bone marrow-derived myeloid-derived suppressor cell (MDSC) differentiation and suppressive function, and macrophage polarization were evaluated.  \nResults The combination of STP and anti-PD-1 synergistically suppressed 4T1 tumor growth, reduced the infiltration of immunosuppressive MDSCs and M2-like tumor-associated macrophages, and reactivated CD8⁺ T cells. STP inhibited 4T1 cell proliferation and lactate secretion in a concentration-dependent manner. Furthermore, STP directly reprogrammed MDSCs by inducing MHC II⁺ cell differentiation and attenuating their T cell suppressive capacity via downregulation of immunosuppressive genes. STP also drove M2-to-M1 macrophage repolarization. Importantly, STP exhibited no direct T cell-activating effects.  \nConclusions Our work establishes STP as a potent remodeler of the immunosuppressive tumor microenvironment that synergizes with anti-PD-1 therapy, providing a novel strategy to overcome ICB resistance.  \n†Zhiqi Xie, Kexin Wang and Jiayi Liu contributed equally to this work.  \n*Correspondence: Zhiqi Xie [xiezq@hzcu.edu.cn](xiezq@hzcu.edu.cn)[ ](xiezq@hzcu.edu.cn)Zeren Shen [zrshen@zju.edu.cn](zrshen@zju.edu.cn)[ ](zrshen@zju.edu.cn)Jinjin Shao [shaojinjin@hmc.edu.cn](shaojinjin@hmc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nXie et al. BMC Cancer (2026) 26:439 Page 2 of 11  \nKeywords Stiripentol, Myeloid-derived suppressor cells, Tumor-associated macrophages, Immunotherapy, PD-1  \nBackground  \nCancer remains a global health challenge with profound clinical consequences. Central to tumor immun","cbCaibEMVCHoWUyr","https://ap.wps.com/l/cbCaibEMVCHoWUyr","pdf",2396982,11,"English","# Abstract\n# Background\n## PD-1/PD-L1 axis and immune resistance\n## Myeloid suppressor cells and tumor-associated macrophages\n## Lactate-enriched TME and LDHA inhibition by STP\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What question does the study investigate about stiripentol (STP) and anti-PD-1?\",\"answer\":\"It tests whether STP directly remodels the immunosuppressive tumor microenvironment and enhances the efficacy of anti-PD-1 therapy.\"},{\"question\":\"How does the combination of STP and anti-PD-1 affect the tumor and immune cells?\",\"answer\":\"The combination suppresses 4T1 tumor growth, reduces immunosuppressive MDSCs and M2-like TAMs, and reactivates CD8+ T cells.\"},{\"question\":\"What immune-suppressive pathways of myeloid cells does STP target?\",\"answer\":\"STP directly reprograms MDSCs by inducing MHC II+ differentiation and downregulating immunosuppressive genes, and it promotes M2-to-M1 macrophage repolarization.\"}]","Stiripentol directly attenuates immunosuppression of tumor-infiltrating myeloid cells to potentiate anti-PD-1 efficacy | PDF",1790108403,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a28e64f69fed8377480753bd628d20a1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7568c662f528fbac1c65e04090c5bb0.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/707c8472f213618253594dada213b390.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0682cf5152c3fac000defef5ed86752b.webp",980,1306]